Outcomes of Medicare Beneficiaries With Heart Failure and Atrial Fibrillation

被引:57
|
作者
Khazanie, Prateeti [1 ,2 ]
Liang, Li [1 ]
Qualls, Laura G. [1 ]
Curtis, Lesley H. [1 ,2 ]
Fonarow, Gregg C. [3 ]
Hammill, Bradley G. [1 ,4 ]
Hammill, Stephen C.
Heidenreich, Paul A. [5 ]
Masoudi, Frederick A. [6 ]
Hernandez, Adrian F. [1 ,2 ]
Piccini, Jonathan P. [1 ,2 ]
机构
[1] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA
[2] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA
[3] Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA USA
[4] Mayo Clin, Rochester, MN USA
[5] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA
[6] Univ Colorado, Aurora, CO USA
基金
美国医疗保健研究与质量局;
关键词
atrial fibrillation; heart failure; Medicare; mortality outcome; assessment (health care); patient readmission; VENTRICULAR SYSTOLIC DYSFUNCTION; PROFILING HOSPITAL PERFORMANCE; OPTIMIZE-HF; MORTALITY; RISK; REGISTRY; STROKE; READMISSION; RIVAROXABAN; PROGRESSION;
D O I
10.1016/j.jchf.2013.11.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives This study sought to examine the long-term outcomes of patients hospitalized with heart failure and atrial fibrillation. Background Atrial fibrillation is common among patients hospitalized with heart failure. Associations of pre-existing and new-onset atrial fibrillation with long-term outcomes are unclear. Methods We analyzed 27,829 heart failure admissions between 2006 and 2008 at 281 hospitals in the American Heart Association's Get With The Guidelines-Heart Failure program linked with Medicare claims. Patients were classified as having pre-existing, new-onset, or no atrial fibrillation. Cox proportional hazards models were used to identify factors that were independently associated with all-cause mortality, all-cause readmission, and readmission for heart failure, stroke, and other cardiovascular disease at 1 and 3 years. Results After multivariable adjustment, pre-existing atrial fibrillation was associated with greater 3-year risks of all-cause mortality (hazard ratio [HR]: 1.14 [99% confidence interval (CI): 1.08 to 1.20]), all-cause readmission (HR: 1.09 [99% CI: 1.05 to 1.14]), heart failure readmission (HR: 1.15 [99% CI: 1.08 to 1.21]), and stroke readmission (HR: 1.20 [99% CI: 1.01 to 1.41]), compared with no atrial fibrillation. There was also a greater hazard of mortality at 1 year among patients with new-onset atrial fibrillation (HR: 1.12 [99% CI: 1.01 to 1.24]). Compared with no atrial fibrillation, newonset atrial fibrillation was not associated with a greater risk of the readmission outcomes. Stroke readmission rates at 1 year were just as high for patients with preserved ejection fraction as for patients with reduced ejection fraction. Conclusions Both pre-existing and new-onset atrial fibrillation were associated with greater long-term mortality among older patients with heart failure. Pre-existing atrial fibrillation was associated with greater risk of readmission. (C) 2014 by the American College of Cardiology Foundation
引用
收藏
页码:41 / 48
页数:8
相关论文
共 50 条
  • [1] OUTCOMES OF MEDICARE BENEFICIARIES WITH HEART FAILURE AND ATRIAL FIBRILLATION
    Khazanie, Prateeti
    Liang, Li
    Qualls, Laura
    Curtis, Lesley
    Fonarow, Gregg
    Hammill, Bradley
    Hammill, Stephen
    Heidenreich, Paul
    Masoudi, Frederick
    Hernandez, Adrian
    Piccini, Jonathan
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E733 - E733
  • [2] Outcomes associated with comorbid atrial fibrillation and heart failure in medicare beneficiaries with acute coronary syndrome
    Chen, Shih-Yin
    Crivera, Concetta
    Stokes, Michael
    Boulanger, Luke
    Schein, Jeff
    [J]. BMC HEALTH SERVICES RESEARCH, 2014, 14
  • [3] Outcomes associated with comorbid atrial fibrillation and heart failure in medicare beneficiaries with acute coronary syndrome
    Shih-Yin Chen
    Concetta Crivera
    Michael Stokes
    Luke Boulanger
    Jeff Schein
    [J]. BMC Health Services Research, 14
  • [4] Outcomes of Medicare Beneficiaries Undergoing Catheter Ablation for Atrial Fibrillation
    Piccini, Jonathan P.
    Sinner, Moritz F.
    Greiner, Melissa A.
    Hammill, Bradley G.
    Fontes, Joao D.
    Daubert, James P.
    Ellinor, Patrick T.
    Hernandez, Adrian F.
    Walkey, Allan J.
    Heckbert, Susan R.
    Benjamin, Emelia J.
    Curtis, Lesley H.
    [J]. CIRCULATION, 2012, 126 (18) : 2200 - +
  • [5] Pharmacotherapy in Medicare beneficiaries with atrial fibrillation
    Piccini, Jonathan P.
    Mi, Xiaojuan
    DeWald, Tracy A.
    Go, Alan S.
    Hernandez, Adrian F.
    Curtis, Lesley H.
    [J]. HEART RHYTHM, 2012, 9 (09) : 1403 - 1408
  • [6] Kidney Outcomes Among Medicare Beneficiaries After Hospitalization for Heart Failure
    Ostrominski, John W.
    Greene, Stephen J.
    Patel, Ravi B.
    Solomon, Nicole C.
    Chiswell, Karen
    DeVore, Adam D.
    Butler, Javed
    Heidenreich, Paul A.
    Huang, Joanna C.
    Kittleson, Michelle M.
    Joynt Maddox, Karen E.
    Linganathan, Karthik K.
    Mcdermott, James J.
    Owens, Anjali Tiku
    Peterson, Pamela N.
    Solomon, Scott D.
    Vardeny, Orly
    Yancy, Clyde W.
    Fonarow, Gregg C.
    Vaduganathan, Muthiah
    [J]. JAMA CARDIOLOGY, 2024, 9 (07) : 667 - 672
  • [7] Use and effectiveness of warfarin in medicare beneficiaries with atrial fibrillation
    Birman-Deych, E
    Radford, MJ
    Nilasena, DS
    Gage, BF
    [J]. STROKE, 2006, 37 (04) : 1070 - 1074
  • [8] Impact of Atrial Fibrillation on Outcomes in Heart Failure
    DePasquale, Eugene C.
    Fonarow, Gregg C.
    [J]. HEART FAILURE CLINICS, 2013, 9 (04) : 437 - +
  • [9] Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation
    Gage, BF
    Boechler, M
    Doggette, AL
    Fortune, G
    Flaker, GC
    Rich, MW
    Radford, MJ
    [J]. STROKE, 2000, 31 (04) : 822 - 827
  • [10] OUTCOMES OF OFF-LABEL DOSING OF DIRECT ORAL ANTICOAGULANTS IN MEDICARE BENEFICIARIES WITH ATRIAL FIBRILLATION
    Briasoulis, Alexandros
    Gao, Yubo
    Vaughan-Sarrazin, Mary
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 367 - 367